Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.
Freeman CL, Dixon M, Houghton R, Kreuzer KA, Fingerle-Rowson G, Herling M, Humphrey K, Böttcher S, de Costa CS, Iglesias V, Stilgenbauer S, Gribben J, Hallek M, Goede V. Freeman CL, et al. Leukemia. 2016 Aug;30(8):1763-6. doi: 10.1038/leu.2016.41. Epub 2016 Mar 4. Leukemia. 2016. PMID: 26979130 Free PMC article. No abstract available.
Perifosine--a new option in treatment of acute myeloid leukemia?
Krawczyk J, Keane N, Swords R, O'Dwyer M, Freeman CL, Giles FJ. Krawczyk J, et al. Expert Opin Investig Drugs. 2013 Oct;22(10):1315-27. doi: 10.1517/13543784.2013.826648. Epub 2013 Aug 9. Expert Opin Investig Drugs. 2013. PMID: 23931614 Review.
5-Azacytidine for the treatment of myelodysplastic syndromes.
Krawczyk J, Keane N, Freeman CL, Swords R, O'Dwyer M, Giles FJ. Krawczyk J, et al. Expert Opin Pharmacother. 2013 Jun;14(9):1255-68. doi: 10.1517/14656566.2013.794222. Epub 2013 Apr 27. Expert Opin Pharmacother. 2013. PMID: 23621771 Review.
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL).
Freeman CL, Gribben JG. Freeman CL, et al. Curr Hematol Malig Rep. 2016 Feb;11(1):29-36. doi: 10.1007/s11899-015-0295-9. Curr Hematol Malig Rep. 2016. PMID: 26857283 Free PMC article. Review.
1,118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page